Incyte Corporation revenue breakdown overview

Incyte Corporation revenue for the last year amounted to 3.70 B USD, the most of which — 3.70 B USD — came from its highest performing source at the moment, Proprietary Therapeutics, the year earlier bringing 3.39 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Incyte Corporation 3.50 B USD, and the year before that — 3.20 B USD.